imipenem, anhydrous has been researched along with Infective Endocarditis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, I; Bizzini, A; Entenza, JM; Erni, B; Michielin, O; Moreillon, P | 1 |
| Aiezza, N; Antonelli, A; Bernardo, M; De Vivo, S; Di Luca, M; Pini, M; Rossolini, GM; Tascini, C | 1 |
| Abdelhady, W; Bayer, AS; Estellés, A; Gonzales, R; Kauvar, LM; Leighton, A; Li, L; Ryser, S; Tenorio, E; Xiong, YQ | 1 |
| Almela, M; Cruceta, A; de Alarcón, A; Del Río, A; Eworo, A; García-de-la-Mària, C; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Muñoz, P; Paré, JC; Peña, C; Pericàs, JM | 1 |
| Brandt, CM; Laue, NW; Rouse, MS; Steckelberg, JM; Stratton, CW; Wilson, WR | 1 |
| Archer, GL; Climo, MW; Hale-Cooper, CG; Markowitz, SM; Williams, DS | 1 |
| Caballero, FJ; Cuberos, L; García-Curiel, A; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ | 1 |
| Berenguer, J; Bouza, E; Ena, J; Peláez, T | 1 |
1 trial(s) available for imipenem, anhydrous and Infective Endocarditis
| Article | Year |
|---|---|
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Endocarditis; Female; Fosfomycin; Humans; Imipenem; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vancomycin | 2018 |
7 other study(ies) available for imipenem, anhydrous and Infective Endocarditis
| Article | Year |
|---|---|
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Carbohydrate Metabolism; Chromosome Mapping; Cloning, Molecular; Dimerization; DNA, Bacterial; Endocarditis; Energy Metabolism; Gene Deletion; Genetic Linkage; Glucose; Microbial Sensitivity Tests; Models, Molecular; Penicillin Resistance; Penicillins; Phosphoenolpyruvate Sugar Phosphotransferase System; Point Mutation; Protein Conformation; Streptococcus gordonii; Transformation, Genetic | 2010 |
Infective Endocarditis Associated with Implantable Cardiac Device by Metallo-β-Lactamase-Producing Pseudomonas aeruginosa, Successfully Treated with Source Control and Cefiderocol Plus Imipenem.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Defibrillators, Implantable; Endocarditis; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2023 |
A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aortic Valve; Biofilms; Drug Therapy, Combination; Endocarditis; Epitopes; Female; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2017 |
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cell Wall; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis; Enterococcus faecium; Imipenem; Microbial Sensitivity Tests; Rabbits; Vancomycin | 1996 |
Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
Topics: Animals; Bacteriological Techniques; beta-Lactam Resistance; Ceftizoxime; Drug Resistance, Microbial; Endocarditis; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Rabbits; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 1997 |
Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Endocarditis; Heart Valves; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Rabbits; Sulbactam; Survival Rate; Time Factors | 2001 |
Endocarditis caused by Corynebacterium group D2.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Corynebacterium Infections; Endocarditis; Humans; Imipenem; Male; Species Specificity; Vancomycin | 1991 |